Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8553282.
- Also identified by PMC identifier 475098.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 67 year old woman developed a severe adenoviral pneumonitis whilst receiving immunosuppressive therapy. She showed clinical and radiological evidence of a response to treatment with nebulised and intravenous ribavirin and intravenous pooled normal human immunoglobulin. To our knowledge this is the first time that such a therapeutic approach has been used in the treatment of a condition which normally carries a very high mortality.
Medical subject headings
- Adenoviridae Infections
- Antiviral Agents
- Immunoglobulins, Intravenous
- Pneumonia, Viral
- Ribavirin